Immediate and late effects of coronary angiography on soluble endothelial cell markers and P-selectin in patients with and without coronary artery disease
F. Warzok et al., Immediate and late effects of coronary angiography on soluble endothelial cell markers and P-selectin in patients with and without coronary artery disease, BL COAG FIB, 10(6), 1999, pp. 381-387
Endothelial cell injury and platelet activation are considered primary even
ts in the pathogenesis of coronary artery disease (CAD) and are marked by p
lasma concentrations of von Willebrand factor (vWF) and soluble thrombomodu
lin, and by soluble P-selectin, respectively. Because both endothelial cell
s and platelets interact with contrast media, we aimed to detect immediate
and 24-h changes in these markers following coronary angiography in patient
s with and without CAD. Sixteen patients with angiographically proven CAD a
nd 14 patients without significant coronary stenosis were investigated. Blo
od samples were obtained from an antecubital vein before and 24 h after car
diac catheterization, and from the coronary sinus before and immediately af
ter angiography. Concentrations of the markers were determined using enzyme
-linked immunosorbent assays. In the coronary sinus samples, the only signi
ficant finding was an increase in levels of soluble P-selectin in the patie
nts with CAD (P < 0.038). In the post-catheterization peripheral blood samp
les, concentrations of soluble P-selectin (P = 0.004), vWF (P = 0.0007) and
soluble thrombomodulin (P = 0.0013) were all increased in patients with CA
D. In contrast, patients without CAD demonstrated increased levels of vWF o
nly (P = 0.0015) in peripheral blood samples obtained 24 h after angiograph
y. We conclude that both immediate and 24-h changes take place in endotheli
al cells and platelet markers in response to cardiac catheterization, and t
hat these changes are different in patients with angiographically proven CA
D and in patients free of disease. These differences may reflect alteration
s in endothelial cell or platelet reactivity in patients with CAD. Blood Co
ag Fibrinol 10:381-387 (C) 1999 Lippincott Williams & Wilkins.